Heparin and related polysaccharides: synthesis using recombinant enzymes and metabolic engineering
Gespeichert in:
Verfasser / Beitragende:
[Matthew Suflita, Li Fu, Wenqin He, Mattheos Koffas, Robert Linhardt]
Ort, Verlag, Jahr:
2015
Enthalten in:
Applied Microbiology and Biotechnology, 99/18(2015-09-01), 7465-7479
Format:
Artikel (online)
Online Zugang:
| LEADER | caa a22 4500 | ||
|---|---|---|---|
| 001 | 605501351 | ||
| 003 | CHVBK | ||
| 005 | 20210128100600.0 | ||
| 007 | cr unu---uuuuu | ||
| 008 | 210128e20150901xx s 000 0 eng | ||
| 024 | 7 | 0 | |a 10.1007/s00253-015-6821-9 |2 doi |
| 035 | |a (NATIONALLICENCE)springer-10.1007/s00253-015-6821-9 | ||
| 245 | 0 | 0 | |a Heparin and related polysaccharides: synthesis using recombinant enzymes and metabolic engineering |h [Elektronische Daten] |c [Matthew Suflita, Li Fu, Wenqin He, Mattheos Koffas, Robert Linhardt] |
| 520 | 3 | |a Glycosaminoglycans are linear anionic polysaccharides that exhibit a number of important biological and pharmacological activities. The two most prominent members of this class of polysaccharides are heparin/heparan sulfate and the chondroitin sulfates (including dermatan sulfate). These polysaccharides, having complex structures and polydispersity, are biosynthesized in the Golgi of most animal cells. The chemical synthesis of these glycosaminoglycans is precluded by their structural complexity. Today, we depend on food animal tissues for their isolation and commercial production. Ton quantities of these glycosaminoglycans are used annually as pharmaceuticals and nutraceuticals. The variability of animal-sourced glycosaminoglycans, their inherent impurities, the limited availability of source tissues, the poor control of these source materials, and their manufacturing processes suggest a need for new approaches for their production. Over the past decade, there have been major efforts in the biotechnological production of these glycosaminoglycans. This mini-review focuses on the use of recombinant enzymes and metabolic engineering for the production of heparin and chondroitin sulfates. | |
| 540 | |a Springer-Verlag Berlin Heidelberg, 2015 | ||
| 690 | 7 | |a Glycosaminoglycans |2 nationallicence | |
| 690 | 7 | |a Chemoenzymatic |2 nationallicence | |
| 690 | 7 | |a Metabolic engineering |2 nationallicence | |
| 690 | 7 | |a Recombinant enzymes |2 nationallicence | |
| 690 | 7 | |a Heparin |2 nationallicence | |
| 690 | 7 | |a Chondroitin sulfate |2 nationallicence | |
| 690 | 7 | |a Sulfotransferases |2 nationallicence | |
| 690 | 7 | |a Glycosyltransferases |2 nationallicence | |
| 690 | 7 | |a PAPS |2 nationallicence | |
| 700 | 1 | |a Suflita |D Matthew |u Department of Biology, Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, 121806, Troy, NY, USA |4 aut | |
| 700 | 1 | |a Fu |D Li |u Department of Chemistry and Chemical, Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, 121806, Troy, NY, USA |4 aut | |
| 700 | 1 | |a He |D Wenqin |u Department of Chemical and Biological Engineering, Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, 121806, Troy, NY, USA |4 aut | |
| 700 | 1 | |a Koffas |D Mattheos |u Department of Biology, Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, 121806, Troy, NY, USA |4 aut | |
| 700 | 1 | |a Linhardt |D Robert |u Department of Biology, Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, 121806, Troy, NY, USA |4 aut | |
| 773 | 0 | |t Applied Microbiology and Biotechnology |d Springer Berlin Heidelberg |g 99/18(2015-09-01), 7465-7479 |x 0175-7598 |q 99:18<7465 |1 2015 |2 99 |o 253 | |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s00253-015-6821-9 |q text/html |z Onlinezugriff via DOI |
| 898 | |a BK010053 |b XK010053 |c XK010000 | ||
| 900 | 7 | |a Metadata rights reserved |b Springer special CC-BY-NC licence |2 nationallicence | |
| 908 | |D 1 |a review-article |2 jats | ||
| 949 | |B NATIONALLICENCE |F NATIONALLICENCE |b NL-springer | ||
| 950 | |B NATIONALLICENCE |P 856 |E 40 |u https://doi.org/10.1007/s00253-015-6821-9 |q text/html |z Onlinezugriff via DOI | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Suflita |D Matthew |u Department of Biology, Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, 121806, Troy, NY, USA |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Fu |D Li |u Department of Chemistry and Chemical, Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, 121806, Troy, NY, USA |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a He |D Wenqin |u Department of Chemical and Biological Engineering, Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, 121806, Troy, NY, USA |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Koffas |D Mattheos |u Department of Biology, Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, 121806, Troy, NY, USA |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Linhardt |D Robert |u Department of Biology, Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, 121806, Troy, NY, USA |4 aut | ||
| 950 | |B NATIONALLICENCE |P 773 |E 0- |t Applied Microbiology and Biotechnology |d Springer Berlin Heidelberg |g 99/18(2015-09-01), 7465-7479 |x 0175-7598 |q 99:18<7465 |1 2015 |2 99 |o 253 | ||